Financials
- Market Capitalization 46.66 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.49
Relación precio/flujo de caja
-5.21
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4274 | VERU Veru Inc. - Common Stock | 2.70 USD | +0.37% | -1.82% | +16.38% | +12.97% | 46.04 M USD | ||
| 4275 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.17 USD | +2.72% | +7.82% | -0.83% | +714.77% | 46.69 M USD | ||
| 4289 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.17 USD | 0.00% | -4.10% | -1.68% | -18.75% | 44.20 M USD | ||
| 4293 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.27 USD | -3.57% | -3.57% | -20.59% | -84.92% | 43.12 M USD |